Helen Scarnati

638 total citations
12 papers, 518 citations indexed

About

Helen Scarnati is a scholar working on Infectious Diseases, Virology and Molecular Biology. According to data from OpenAlex, Helen Scarnati has authored 12 papers receiving a total of 518 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Infectious Diseases, 9 papers in Virology and 2 papers in Molecular Biology. Recurrent topics in Helen Scarnati's work include HIV/AIDS drug development and treatment (10 papers), HIV Research and Treatment (9 papers) and HIV/AIDS Research and Interventions (6 papers). Helen Scarnati is often cited by papers focused on HIV/AIDS drug development and treatment (10 papers), HIV Research and Treatment (9 papers) and HIV/AIDS Research and Interventions (6 papers). Helen Scarnati collaborates with scholars based in United States and United Kingdom. Helen Scarnati's co-authors include Dean L. Winslow, David Baker, Lee T. Bacheler, Sena Garber, R.J. Tritch, Susan Jeffrey, Karen Gallagher, Beverly C. Cordova, Kurt Hertogs and Richard T. D’Aquila and has published in prestigious journals such as Journal of Virology, Biochemical and Biophysical Research Communications and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Helen Scarnati

12 papers receiving 490 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Helen Scarnati United States 9 444 434 68 56 41 12 518
Dorien de Jong Netherlands 13 779 1.8× 790 1.8× 101 1.5× 95 1.7× 68 1.7× 23 902
Christel Van den Eynde Belgium 8 640 1.4× 592 1.4× 79 1.2× 126 2.3× 120 2.9× 13 764
Dana N. Raugi United States 15 415 0.9× 395 0.9× 109 1.6× 131 2.3× 35 0.9× 26 578
Lynne Whittaker United Kingdom 10 174 0.4× 113 0.3× 64 0.9× 143 2.6× 17 0.4× 16 351
Bonnie Spira Canada 11 790 1.8× 718 1.7× 117 1.7× 178 3.2× 49 1.2× 17 915
Hideka Miura Japan 11 266 0.6× 205 0.5× 121 1.8× 294 5.3× 23 0.6× 22 597
Salvatore Dimonte Italy 10 260 0.6× 212 0.5× 104 1.5× 134 2.4× 94 2.3× 28 402
Tania Ivens Belgium 9 624 1.4× 473 1.1× 95 1.4× 214 3.8× 220 5.4× 14 772
Maxwell D. Leslie United States 9 250 0.6× 218 0.5× 75 1.1× 96 1.7× 33 0.8× 11 313
Jay A. Levy United States 7 203 0.5× 223 0.5× 54 0.8× 164 2.9× 13 0.3× 8 397

Countries citing papers authored by Helen Scarnati

Since Specialization
Citations

This map shows the geographic impact of Helen Scarnati's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helen Scarnati with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helen Scarnati more than expected).

Fields of papers citing papers by Helen Scarnati

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Helen Scarnati. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helen Scarnati. The network helps show where Helen Scarnati may publish in the future.

Co-authorship network of co-authors of Helen Scarnati

This figure shows the co-authorship network connecting the top 25 collaborators of Helen Scarnati. A scholar is included among the top collaborators of Helen Scarnati based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Helen Scarnati. Helen Scarnati is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Guo, Qi, Hsu‐Tso Ho, Ira B. Dicker, et al.. (2003). Biochemical and Genetic Characterizations of a Novel Human Immunodeficiency Virus Type 1 Inhibitor That Blocks gp120-CD4 Interactions. Journal of Virology. 77(19). 10528–10536. 130 indexed citations
2.
King, Robert W., et al.. (2002). Selection of a Thiazole Urea-Resistant Variant of Bovine Viral Diarrhoea Virus That Maps to the RNA-Dependent RNA Polymerase. Antiviral chemistry & chemotherapy. 13(5). 315–323. 15 indexed citations
3.
Bacheler, Lee T., Susan Jeffrey, George J. Hanna, et al.. (2001). Genotypic Correlates of Phenotypic Resistance to Efavirenz in Virus Isolates from Patients Failing Nonnucleoside Reverse Transcriptase Inhibitor Therapy. Journal of Virology. 75(11). 4999–5008. 187 indexed citations
4.
Bukhtiyarova, Marina, Christopher J. Rizzo, Charles A. Kettner, et al.. (2001). Inhibition of the Bovine Viral Diarrhoea Virus NS3 Serine Protease by a Boron-Modified Peptidyl Mimetic of its Natural Substrate. Antiviral chemistry & chemotherapy. 12(6). 367–373. 20 indexed citations
5.
Winslow, Dean L., Sena Garber, Carol Reid, et al.. (1996). Selection conditions affect the evolution of specific mutations in the reverse transcriptase gene associated with resistance to DMP 266. AIDS. 10(11). 1205–1209. 44 indexed citations
6.
Winslow, Dean L., et al.. (1995). Limited Sequence Diversity of the HIV Type 1 Protease Gene from Clinical Isolates and in Vitro Susceptibility to HIV Protease Inhibitors. AIDS Research and Human Retroviruses. 11(1). 107–113. 46 indexed citations
7.
8.
Winslow, Dean L., Carol Reid, Sena Garber, et al.. (1995). DMP450, a new cyclic urea inhibitor of HIV protease with potent in vitro antiviral activity. Antiviral Research. 26(3). A237–A237. 4 indexed citations
9.
Winslow, Dean L., et al.. (1994). In vitro susceptibility of clinical isolates of HIV-1 to XM323, a non-peptidyl HIV protease inhibitor. AIDS. 8(6). 753–756. 5 indexed citations
10.
Winslow, Dean L., Elizabeth D. Anton, Robert A. Horlick, et al.. (1994). Construction of Infectious Molecular Clones of HIV-1 Containing Defined Mutations in the Protease Gene. Biochemical and Biophysical Research Communications. 205(3). 1651–1657. 11 indexed citations
11.
Reid, Carol, et al.. (1993). XM323, a novel non-peptidyl inhibitor of HIV protease with potent in vitro antiviral activity. 34. 1 indexed citations
12.
Otto, Michaël, Carol Reid, Sena Garber, et al.. (1993). In vitro anti-human immunodeficiency virus (HIV) activity of XM323, a novel HIV protease inhibitor. Antimicrobial Agents and Chemotherapy. 37(12). 2606–2611. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dorien de Jong Breakdown of academic impact, for papers by Christel Van den Eynde Breakdown of academic impact, for papers by Dana N. Raugi Breakdown of academic impact, for papers by Lynne Whittaker Breakdown of academic impact, for papers by Bonnie Spira Breakdown of academic impact, for papers by Hideka Miura Breakdown of academic impact, for papers by Salvatore Dimonte Breakdown of academic impact, for papers by Tania Ivens Breakdown of academic impact, for papers by Maxwell D. Leslie Breakdown of academic impact, for papers by Jay A. Levy
Rankless by CCL
2026